Major chronic diseases and mortalities investigated in one comprehensive study. Large sample size allowed subgroup analyses and control for multiple confounders, including lifestyle information and ...

Mohan didn’t connect her symptoms to the herbal pills. Not until she saw an NBC News report in May on the growing rates of ...

Introduction Liver cirrhosis and other chronic liver diseases is a serious public health problem, and its incidence, morbidity, and mortality have increased in recent years (1). In 2019, 1691.0 ...

Objective Phase II trials suggest glucagon-like peptide-1 receptor (GLP1) agonists resolve metabolic dysfunction-associated steatohepatitis but do not affect fibrosis regression. We aimed to determine ...

Cirrhosis, a chronic liver disease, progressively replaces healthy cells with scar tissue, impairing detoxification and ...